According to Calliditas Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.07. In 2022 the company made an earnings per share (EPS) of -$1.61 an increase over its 2021 EPS that were of -$2.24.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$1.07 | -33.61% |
2022 | -$1.61 | -28.08% |
2021 | -$2.24 | 6.38% |
2020 | -$2.10 | 9973.2% |
2019 | -$0.02086 | -96.7% |
2018 | -$0.63 | -0.64% |
2017 | -$0.64 |